Business Wire

LYFECYCLE

29.8.2021 11:50:06 CEST | Business Wire | Press release

Share
Lyfecycle, Extreme E and Neat Burger release limited edition Greenland 2021 ‘Reach for Change’ bracelet

Lyfecycle has teamed up with plant-based burger chain Neat Burger and Extreme E, the electric offroad racing series, on a mission to build greater awareness about plastic pollution and the need for action, through the creation of a ‘Reach for Change’ limited edition bracelet.

Lyfecycle, created by British innovators Polymateria, aims to tackle the global plastic pandemic. Lyfecycle’s unique technology allows every chance for recycling to happen and offers a “Plan B” for the 32 per cent of plastic that escapes the circular economy and winds up in the natural environment. Through time-set biodegradation, Lyfecycle products return to nature in a little over a year, leaving no toxins or microplastics behind, compared to the thousands of years it is estimated that typical plastics take to break down.

It is estimated that the Arctic Ocean ice contains 12,000 particles of microplastic per litre – higher than in any other ocean in the world. Scientists predict that over time these small particles trap heat within sea ice, which accelerates melting associated with global climate change.

Inspired by nature and powered by science, the ‘Reach for Change’ bracelet features one-of-a-kind sustainable beads repurposed from Lyfecycle cups used at Extreme E’s Arctic X Prix, an adjustable cord from recovered plastic bottles, and a recycled fair trade silver emblem. It is a tangible example of how Lyfecycle materials designed for biodegradation can also be upcycled into high value items such as jewellery thanks to the unique time-set biodegradation property. Redefining the way we think about and design plastics is essential if we are to solve the plastic pandemic.

All bracelets also come with some educational facts about plastic pollution and the steps we can all adopt to help us to lower our daily usage, and recycle more. It serves as a daily reminder that small actions when multiplied by millions contribute to a big change.

The campaign is set to launch during the 2021 Extreme E race in Kangerlussuaq, where attendees will be asked to get involved and help spread the message.

The competition will also be extended to Game Changers across the world, who are taking small steps toward making a positive impact on the environment. Consumers are encouraged to enter for a chance to win at www.lyfecycle.com/reachforchange . 50 winners will be announced on September 15, 2021. Each winner will receive two bracelets, one for themselves and one to gift to another Game Changer.

Niall Dunne, CEO of Polymateria said: “Our collaboration with fellow disruptors Neat Burger and Extreme E is to provide industry with an example of how recycling and biodegradation can work together and put consumers at the heart of the type of change we need to see to address plastic pollution at scale.”

Alejandro Agag, Founder and CEO of Extreme E said: “Extreme E is a platform to accelerate change. We bring disruptive innovators together and push boundaries not only in motorsport but across all industries. It is the adoption of new technologies that we want to promote because they have the power to improve our world.

“Lyfecycle is a great example of a solution to plastic pollution that works and can be scaled immediately whereas the limited-edition bracelet is a reminder that everyone has a role to play and action has to come from every corner.”

Stasi Nychas, Co-Founder and COO at Neat Burger said: “We are delighted to team up with Lyfecycle on a campaign that echoes our values. As the world’s first plant-based sustainable burger chain, we are committed to championing environmental sustainability and playing our part in positively impacting the environment. Therefore, we are proud to have partnered with Lyfecycle, whose team is dedicated to spreading awareness and promoting solutions to plastic pollution.”

NOTES TO EDITORS

About Lyfecycle:

Lyfecycle is a new solution from British Innovators Polymateria to tackle the global plastic pandemic. The unique Lyfecycle technology allows every chance for recycling to happen and offers a “Plan B” for the 32% of plastic that escapes the circular economy and winds up in the natural environment. Through time-set biodegradation, Lyfecycle products return to nature in a little over a year leaving no toxins and microplastics behind.

Lyfecycle packaging solutions give individuals a more easily achievable way to take small actions toward responsible disposal that will have an immediate and global positive impact on the environment. Through collaborative partnerships, awareness building, and scientific innovation, Lyfecycle’s goal is to ignite action and cause a ripple effect that will solve ocean pollution, and leave the planet in a better place for generations to come.

About Extreme E:

Extreme E is a radical new racing series, which will see electric SUVs competing in extreme environments around the world which have already been damaged or affected by climate and environmental issues. The five-race global voyage highlights the impact of climate change and human interference in some of the world’s most remote locations and promotes the adoption of electric vehicles in the quest for a lower carbon future for the planet.

About Neat Burger:

Founded in collaboration with F1 legend Lewis Hamilton, the group is loved by plant-based and meat eaters alike, serving up a fresh approach to vegan dining while satisfying everyone’s craving for American style food that tastes just like the real thing. Neat Burger works in association with The Eden Projects where for every product sold, a tree is planted.

About Anchor & Crew:

Combining British craft manufacturing with a discerning modern-minimalist style, ANCHOR & CREW is a jewellery and accessories brand that is both multi-award winning ever since 2014 and believers in having a highly ethical and traceable supply chain. ANCHOR & CREW is driven to empower consumers to make the right choice with radical transparency and enact change within their industry.

Honorable Mentions:

Carbon-neutral cup supplier Cupstorys, Imperial College London, Protolabs, and Lyfecycle’s own innovation labs that made this unique piece of jewellery possible.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye